Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Director/PDMR Shareholding

27 Jun 2007 14:50

Halma PLC27 June 2007 HALMA p.l.c. DIRECTORS AND PDMR INCREASE SHAREHOLDINGS At a Meeting of the Share Plans Committee of the Board of Halma p.l.c. held on 26 June 2007, atotal of 206,100 additional ordinary shares in the Company were allotted under the provisions ofthe Company's Share Option Plans to Directors and PDMRs of the Company, following the exercise ofshare options, as set out below. Following the execution of the net transactions noted below, the total shareholdings of theDirectors and PDMRs increased by 44,900 shares. Kevin Thompson, Director 30,400 shares were allotted to Kevin Thompson at an exercise price of 122.50p. To finance the exercise of this share option, Kevin Thompson sold 15,708 shares on 26 June 2007 at237.745p per share. After the above transactions, the beneficial holding of Kevin Thompson, including family interests,in the ordinary shares of Halma p.l.c. increases by 14,692 shares to 114,301 shares (0.031% of theissued ordinary share capital excluding treasury shares). Neil Quinn, Director 142,100 ordinary shares were allotted to Neil Quinn. The exercise prices were as follows: No of shares Price per share 10,700 120.00p 131,400 111.00p To finance the exercise of these share options and the associated tax, Neil Quinn sold 137,100 shares on 26June 2007 at 237.745p per share. After the above transactions, the beneficial holding of Neil Quinn in the ordinary shares of Halma p.l.c.increases by 5,000 shares to 74,118 shares (0.02% of the issued ordinary share capital excluding treasuryshares). Keith Roy, Director 11,800 shares were allotted to Keith Roy at an exercise price of 122.50p per share. To finance the exercise of these share options and the associated tax liability, Keith Roy sold8,392 shares on 26 June 2007 at 237.745p per share. After the above transactions, the beneficial holding of Keith Roy, including family interests, inthe ordinary shares of Halma p.l.c. increases by 3,408 shares to 764,057 shares (0.205% of theissued ordinary share capital excluding treasury shares). John Campbell, PDMR 10,000 shares were allotted to John Campbell at an exercise price of 120.00p per share. After the above transaction, the beneficial holding of John Campbell, including family interests,in the ordinary shares of Halma p.l.c. as at 26 June 2007 increases by 10,000 shares to 49,631shares (0.013% of the issued ordinary share capital excluding treasury shares). Issued ordinary share capital Following the issue of ordinary shares as a result of the share options exercised on 26 June 2007, the issuedordinary share capital, excluding treasury shares, of the Company is increased to 372,640,160 shares. Contact for further information: Andrew Williams Chief Executive, Halma p.l.c. Tel: +44 (0)1494 721111 A copy of this announcement, together with other information about Halma, may be viewed on its website:www.halma.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th May 20267:15 amRNSExecutive Board changes
13th Apr 20267:00 amRNSAcquisition
12th Mar 20267:00 amRNSTrading Update
13th Jan 20269:18 amRNSDirector/PDMR Shareholding
9th Jan 20261:26 pmRNSDirector/PDMR Shareholding
9th Jan 20267:00 amRNSAcquisition
5th Dec 20257:00 amRNSAcquisition
20th Nov 20257:00 amRNSHalf Year Results
1st Oct 20252:00 pmRNSDirector/PDMR Shareholding
26th Sep 202510:19 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTrading Update
26th Aug 20257:00 amRNSAcquisition
24th Jul 20252:15 pmRNSResult of AGM
30th Jun 202511:30 amRNSDirector/PDMR Shareholding
25th Jun 20258:30 amRNSAGM - Revised Form of Proxy
24th Jun 20259:20 amRNSDirector/PDMR Shareholding
20th Jun 20255:15 pmRNSAnnual Financial Report
18th Jun 20254:47 pmRNSDirector/PDMR Shareholding
12th Jun 20257:00 amRNSFull Year Results
16th May 20257:00 amRNSDirectorate Change
28th Mar 20251:10 pmRNSDirector/PDMR Shareholding
21st Mar 20252:00 pmRNSDirectorate Change
13th Mar 20257:00 amRNSTrading Update
28th Feb 20254:29 pmRNSDirector/PDMR Shareholding
14th Jan 20252:05 pmRNSDirector/PDMR Shareholding
8th Jan 20257:00 amRNSAppointment of Chief Financial Officer
28th Nov 202410:04 amRNSDirector/PDMR Shareholding
22nd Nov 20243:30 pmRNSDirector/PDMR Shareholding
22nd Nov 20243:26 pmRNSDirector/PDMR Shareholding
21st Nov 20247:00 amRNSHalf Year Results
18th Nov 20247:00 amRNSAcquisition
6th Nov 20242:34 pmRNSDirector Declaration
2nd Oct 20249:20 amRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSTrading Update
24th Sep 20249:45 amRNSDirector/PDMR Shareholding
3rd Sep 20249:15 amRNSPDMR Shareholding
25th Jul 20241:51 pmRNSResult of AGM
24th Jul 20249:15 amRNSDirector/PDMR Shareholding
17th Jul 202412:46 pmRNSDirector Declaration
1st Jul 20249:51 amRNSDirector/PDMR Shareholding
27th Jun 20247:00 amRNSAcquisition
25th Jun 20243:00 pmRNSDirector/PDMR Shareholding
24th Jun 20245:26 pmRNSAnnual Financial Report
13th Jun 20247:00 amRNSFull Year Results
1st May 20247:00 amRNSAcquisition
19th Mar 20243:53 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTrading Update
4th Mar 20247:00 amRNSAcquisition
21st Feb 20244:17 pmRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.